机译:与家族性垂体腺瘤相关的芳基烃受体相互作用蛋白基因的新突变介导肿瘤侵袭和生长激素的折射性
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Pathol Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou Zhejiang Peoples R China;
Loma Linda Univ Sch Med Dept Prevent Med Loma Linda CA USA;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Neurosurg Hangzhou Zhejiang Peoples R China;
AIP; Aryl hydrocarbon receptor interacting protein; Drug resistance; Familial isolated pituitary adenoma; FIPA; Hypersecretion; Mutation; Tumor invasiveness;
机译:与家族性垂体腺瘤相关的芳基烃受体相互作用蛋白基因的新突变介导肿瘤侵袭和生长激素的折射性
机译:家族性垂体腺瘤中芳烃受体相互作用蛋白基因的R304X突变是突变热点还是创始人效应?
机译:家族性垂体腺瘤(FIPA)和芳烃受体相互作用蛋白(AIP)基因突变
机译:与芳烃受体及其伴侣ARNT相互作用并介导其活性的蛋白质。
机译:家族性孤立垂体腺瘤(FIPA)和垂体腺瘤易感性的芳烃受体相互作用蛋白(AIP)基因突变。
机译:家族性孤立的垂体腺瘤(FIPA)和垂体腺瘤倾向引起的芳基烃受体相互作用蛋白(AIP)基因的突变